<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta charset="utf-8" />
		<title>BCSC1718_S04_C01_p001_012</title>
		<link href="BCSC1718_S04_C01_p001_012-web-resources/css/idGeneratedStyles.css" rel="stylesheet" type="text/css" />
	</head>
	<body id="BCSC1718_S04_C01_p001_012" lang="en-US">
		<div id="_idContainer000" class="Basic-Text-Frame">
			<p class="fm-only_fm-objectives-text">Upon completion of BCSC Section 4, <span class="CharOverride-1">Ophthalmic Pathology and Intraocular Tumors,</span> the reader should be able to</p>
			<ul>
				<li class="fm-only_fm-objectives-bullet-list-first">describe a structured approach to understanding major ocular conditions based on a hierarchical framework of topography, disease process, general diagnosis, and differential diagnosis</li>
				<li class="fm-only_fm-objectives-bullet-list-mid">list the steps for handling ocular specimens for pathologic study, including obtaining, dissecting, processing, and staining tissues</li>
				<li class="fm-only_fm-objectives-bullet-list-mid">explain the basic principles of special procedures used in ophthalmic pathology, including immunohistochemistry, flow cytometry, molecular pathology, and diagnostic electron microscopy</li>
				<li class="fm-only_fm-objectives-bullet-list-mid">discuss the types of specimens, processing, and techniques appropriate to the clinical situation</li>
				<li class="fm-only_fm-objectives-bullet-list-mid">describe the histopathology of common ocular conditions</li>
				<li class="fm-only_fm-objectives-bullet-list-mid">discuss the relationship between clinical and pathologic findings in various ocular conditions</li>
				<li class="fm-only_fm-objectives-bullet-list-mid">list the steps in wound healing in ocular tissues</li>
				<li class="fm-only_fm-objectives-bullet-list-mid">state current information about the most common primary tumors of the eye</li>
				<li class="fm-only_fm-objectives-bullet-list-mid">identify those ophthalmic lesions that indicate systemic disease and are potentially life threatening</li>
				<li class="fm-only_fm-objectives-bullet-list-mid">discuss genetic information that would be useful to provide to families affected by retinoblastoma</li>
				<li class="fm-only_fm-objectives-bullet-list-last">describe current treatment modalities for ocular tumors in terms of patient prognosis and ocular function</li>
			</ul>
		</div>
		<div id="_idContainer001" class="Basic-Text-Frame">
			<p class="chapter-number"><span class="cn-chap">Chapter </span>1</p>
			<p class="chapter-title">Introduction to Part I</p>
			<p class="body-text--no-indent-">BCSC Section&#160;4, <span class="italic">Ophthalmic Pathology and Intraocular Tumors,</span> provides a general overview of the fields of ophthalmic pathology and ocular oncology. This book contains numerous illustrations of entities commonly encountered in an ophthalmic pathology laboratory and in the practice of ocular oncology. In addition, important but less common entities are included for teaching purposes. For more comprehensive reviews of ophthalmic pathology and ocular oncology, please refer to the excellent textbooks listed in Basic Texts at the end of this volume.</p>
			<p class="body-text">Ophthalmic pathology is recognized as a subspecialty by the American Academy of Ophthalmology, the American Board of Ophthalmology, the Association of University Professors of Ophthalmology, and the International Council of Ophthalmology. The study of ophthalmic pathology has contributed significantly to understanding the pathogenesis of diseases of the eye and ocular adnexa. The Accreditation Council for Graduate Medical Education (ACGME) requires that resident education in ophthalmic pathology be directed by faculty members with expertise in that field, and the residency training curriculum of the International Council of Ophthalmology stipulates “engage[ment] with an ophthalmic pathologist.” In the United States, ophthalmologists and pathologists may receive subspecialty fellowship training in ophthalmic pathology after completion of an ACGME-&#173;accredited training program in ophthalmology or pathology; some ophthalmic pathologists are board certified in both ophthalmology and pathology.</p>
			<p class="body-text">Part&#160;I of this text provides a framework for the study of ophthalmic pathology according to the following hierarchical organizational paradigm (explained in detail in the next section): topography, disease process, general diagnosis, and differential diagnosis. Chapter&#160;2 briefly covers basic principles and specific aspects of wound repair as it applies to ophthalmic tissues, which exhibit distinct responses to trauma. Chapter&#160;3 discusses specimen handling, including orientation and dissection, and emphasizes the critical communication between the ophthalmologist and the pathologist. Most ophthalmic pathology specimens are routinely processed, and slides are stained with hematoxylin-&#173;eosin. Special procedures such as immunohistochemical staining, flow cytometry, polymerase chain reaction (PCR), and frozen sections are used in selected cases, which will be discussed in Chapter&#160;4. Chapters&#160;5 through 15 apply the organizational paradigm to specific anatomical locations.</p>
			<p class="h1">Organization</p>
				<div id="Chapt1_Top1">
			<p class="body-text--no-indent-">As mentioned, Chapters&#160;5 through 15 are each devoted to a particular ocular structure. Within these chapters, the text is organized from general to specific, according to the following hierarchical framework:</p>
			<ul>
				<li class="bullet-list-first ParaOverride-1">topography</li>
				<li class="bullet-list-mid">disease process</li>
				<li class="bullet-list-mid">general diagnosis</li>
				<li class="bullet-list-last ParaOverride-2">differential diagnosis</li>
			</ul>
			<p class="h2 ParaOverride-3">Topography</p>
			<p class="body-text--no-indent-">A microscopic evaluation of a specimen should begin with a description of any normal tissue. For instance, the topography of the cornea features nonkeratinized stratified squamous epithelium, Bowman layer, stroma, Descemet membrane, and endothelium. By recognizing a particular structure in a biopsy specimen, such as Bowman layer or Descemet membrane, an examiner might be able to identify the specimen in question as cornea. Similarly, the presence of a tarsal plate in a specimen showing the topographic features of keratinized stratified squamous epithelium overlying dermis with dermal appendages may be identified as eyelid skin. See BCSC Section&#160;2, <span class="italic">Fundamentals and Principles of Ophthalmology,</span> for a review of ophthalmic anatomy.</p>
			<p class="h2 ParaOverride-3">Disease Process</p>
			<p class="body-text--no-indent-">After identifying a tissue source, the examiner should attempt to categorize the general disease process. These processes include</p>
			<ul>
				<li class="bullet-list-first ParaOverride-1">congenital anomaly</li>
				<li class="bullet-list-mid">inflammation</li>
				<li class="bullet-list-mid">degeneration and dystrophy</li>
				<li class="bullet-list-last ParaOverride-2">neoplasia</li>
			</ul>
			<p class="h3 ParaOverride-4">Congenital anomaly</p>
			<p class="body-text--no-indent-">Congenital anomalies usually involve abnormalities in size, location, organization, or amount of tissue. One example is congenital hypertrophy of the retinal pigment epithelium (CHRPE) (see Chapter&#160;11, Fig&#160;11-6; and Chapter&#160;17, Fig&#160;17-10). Many congenital abnormalities may be classified as choristomas or hamartomas.</p>
			<p class="body-text">A <span class="italic">choristoma</span> consists of normal, mature tissue (up to 1 or 2&#160;embryonic germ layers) at an abnormal location. An example of a choristoma is a <span class="italic">dermoid:</span> skin that is otherwise normal and mature present in an abnormal location, the limbus. A tumor made up of tissue derived from all 3&#160;embryonic germ layers is called a <span class="italic">teratoma</span> (<span class="xref-figure">Fig&#160;1-1</span>).</p>
			<p class="body-text">In contrast, the term <span class="italic">hamartoma</span> describes hypertrophy and hyperplasia (abnormal amount) of mature tissue at a normal location. An example of a hamartoma is a <span class="italic">cavernous hemangioma,</span> an encapsulated mass of mature venous channels in the orbit.</p>
			<p class="h3 ParaOverride-4">Inflammation</p>
			<p class="body-text--no-indent-">The next disease process in the schema, inflammation, can be classified in several ways. It may be acute or chronic in onset and focal or diffuse in location. Chronic inflammation is classified further as either granulomatous or nongranulomatous. For example, a bacterial corneal ulcer is generally an acute, focal, nongranulomatous inflammation, whereas sympathetic ophthalmia is a chronic, diffuse, granulomatous inflammation.</p>
			<p class="body-text">Polymorphonuclear leukocytes (PMNs), including neutrophils, eosinophils, and basophils, circulate in the blood and may be present in tissue in early phases of the inflammatory process (<span class="xref-figure">Figs&#160;1-2</span>, <span class="xref-figure">1-3</span>, and <span class="xref-figure">1-4</span>). <span class="italic">Neutrophils</span> typify acute inflammatory cells and can be recognized by a multisegmented nucleus and intracytoplasmic granules. They are associated with bacterial infection and may be found in the walls of blood vessels in some forms of vasculitis. <span class="italic">Eosinophils</span> have bilobed nuclei and prominent intracytoplasmic eosinophilic granules. They are commonly found in allergic reactions, although they may also be present in chronic inflammatory processes such as sympathetic ophthalmia. <span class="italic">Basophils</span> contain basophilic intracytoplasmic granules. <span class="italic">Mast cells</span> are the tissue-&#173;bound equivalent of the blood-borne basophils.</p>
			<p class="body-text">Inflammatory cells that are characteristic of chronic inflammatory processes include monocytes (<span class="xref-figure">Fig&#160;1-5</span>) and lymphocytes (<span class="xref-figure">Fig&#160;1-6</span>). <span class="italic">Monocytes</span> that migrate from the intravascular space into tissue are classified as <span class="italic">histiocytes</span> or <span class="italic">macrophages.</span> Histiocytes have eccentric nuclei and abundant eosinophilic cytoplasm. Some histiocytes, known as <span class="italic">epithelioid histiocytes,</span> may take on the appearance of epithelial cells, with abundant eosinophilic cytoplasm and sharp cell borders. Epithelioid histiocytes may form a ball-like aggregate known as a <span class="italic">granuloma,</span> the hallmark of granulomatous inflammation. Granulomas may contain only histologically intact cells (“hard” tubercles, <span class="xref-figure">Fig&#160;1-7</span>), or they may exhibit necrotic centers (“caseating” granulomas, <span class="xref-figure">Fig&#160;1-8</span>). Epithelioid histiocytes may merge to form a <span class="italic">multinucleated giant cell.</span> Giant cells formed from histiocytes come in several varieties, including</p>
			<ul>
				<li class="bullet-list-first">Langhans cells, characterized by a horseshoe arrangement of the nuclei (<span class="xref-figure">Fig&#160;1-9</span>)</li>
				<li class="bullet-list-mid">Touton giant cells, which have an annulus of nuclei surrounded by a lipid-&#173;filled clear zone (<span class="xref-figure">Fig&#160;1-10</span>)</li>
				<li class="bullet-list-last">foreign body giant cells, with haphazardly arranged nuclei (<span class="xref-figure">Fig&#160;1-11</span>)</li>
			</ul>
			<p class="body-text"><span class="italic">Lymphocytes</span> are small cells with round, hyperchromatic nuclei and scant cytoplasm. Circulating lymphocytes infiltrate tissue in all types of chronic inflammatory processes. These cells terminally differentiate in the thymus <span class="italic">(T&#160;cells)</span> or bursa equivalent <span class="italic">(B&#160;cells)</span>. It is not possible to distinguish between B and T&#160;lymphocytes with routine histologic stains. B&#160;cells may produce immunoglobulin and differentiate into <span class="italic">plasma cells,</span> with eccentric “cartwheel,” or “clockface,” nuclei and a perinuclear halo corresponding to the Golgi apparatus. These cells may become completely distended with immunoglobulin and form <span class="italic">Russell bodies.</span> BCSC Section&#160;9, <span class="italic">Intraocular Inflammation and Uveitis,</span> discusses the cells involved in the inflammatory process in depth in Part&#160;I, Ocular Immunology.</p>
			<p class="h3">Degeneration and dystrophy</p>
			<p class="body-text--no-indent-">The term <span class="italic">degeneration</span> refers to a wide variety of tissue changes that may occur over time. Degenerative processes are not usually associated with a proliferation of cells; rather, there is often an accumulation of acellular material or a loss of tissue mass. Extracellular deposits may result from cellular overproduction of normal material or metabolically abnormal material. These processes may occur in response to an injury or an inflammatory process. As used in this book, “degeneration” is an artificial category used to encompass a wide variety of disease processes. Various categories of diseases, such as those due to vascular causes, normal aging, and trauma, could be considered separately. However, in order to efficiently convey the hierarchical scheme used in this book, these causes are lumped under the rubric of “degeneration.” <span class="italic">Dystrophies</span> are defined as usually bilateral, symmetric, inherited conditions that appear to have little or no relationship to environmental or systemic factors.</p>
			<p class="body-text">Degeneration of tissue may be seen in conjunction with other general disease processes. Examples include calcification of the lens (degeneration) in association with a congenital cataract (congenital anomaly); corneal amyloid (degeneration) in association with trachoma (inflammation); and orbital amyloid (degeneration) in association with lymphoma (neoplasm). The ophthalmic manifestations of diabetes mellitus can be classified as degenerative changes associated with a metabolic disease.</p>
			<p class="h3 ParaOverride-5">Neoplasia</p>
			<p class="body-text--no-indent-">A <span class="italic">neoplasm</span> is a stereotypic, monotonous new growth of a specific tissue phenotype. Neoplasms can occur in either benign or malignant forms. Examples found in particular tissues include</p>
			<ul>
				<li class="bullet-list-first">adenoma (benign) versus adenocarcinoma (malignant) in glandular epithelium</li>
				<li class="bullet-list-mid">topography + <span class="italic">oma</span> (benign) versus topography + <span class="italic">sarcoma</span> (malignant) in soft tissue</li>
				<li class="bullet-list-last">hyperplasia/infiltrate (benign) versus leukemia/lymphoma (malignant) in hematopoietic tissue</li>
			</ul>
			<p class="body-text">Some neoplastic proliferations are called <span class="italic">borderline</span> or <span class="italic">indeterminate,</span> because they are difficult to classify histologically as benign or malignant. Although most of the neoplasms illustrated and discussed in this text are classified as benign or malignant, the reader should be aware that tissue evaluation in a particular disease can give only a static portrait of a dynamic process. <span class="xref-table">Table&#160;1-1</span> summarizes the origin, general classification of benign versus malignant, and growth pattern of neoplasms found in various tissues.</p>
			<p class="body-text">The growth patterns described in Table&#160;1-1 are shown in <span class="xref-figure">Figure&#160;1-12</span>. General histologic signs of malignancy include nuclear hyperchromasia and pleomorphism, necrosis, hemorrhage, and mitotic activity.</p>
			<p class="h2">General Diagnosis</p>
			<p class="body-text--no-indent-">After considering the topography and disease process, the examiner formulates the general diagnosis. Recognizing a tissue <span class="italic">index feature</span> is a critical step in arriving at the general diagnosis. Index features are morphologic identifiers that help to define the disease process more specifically. Examples include the presence of pigment in a pigmented neoplasm and necrosis in a necrotizing granulomatous inflammation. The index feature should differentiate the particular specimen from others demonstrating the same general disease process. For instance, retinoblastoma and uveal melanoma are both intraocular malignant neoplasms; the former is a retinal malignancy, and the latter is a uveal tract malignancy. Other index features for distinguishing between these lesions could be “small, round, blue cell tumors” for the retinoblastoma and “melanocytic proliferation” for the melanoma. Although the most basic index features can be recognized without great difficulty, it takes experience and practice to identify subtle index features.</p>
			<p class="h2">Differential Diagnosis</p>
			<p class="body-text--no-indent-">After the examiner has distinguished a key index feature and formulated a general diagnosis, developing a differential diagnosis is the next step before establishing a definitive or specific diagnosis. The differential diagnosis is a limited list of specific conditions resulting from pathologic processes that were identified in the general diagnosis. For instance, the differential diagnosis based on the features of noncaseating granulomatous inflammation of the conjunctiva includes sarcoidosis, foreign body, and fungal and mycobacterial infections. The differential diagnosis of melanocytic proliferation of the conjunctiva includes nevus, primary acquired melanosis, and melanoma.</p>
			<p class="body-text">Readers are encouraged to practice working through the hierarchical framework by verbalizing each step in sequence while examining a pathologic specimen. Chapters&#160;5 through 15 of this book provide tissue-&#173;specific examples of the differential diagnoses for each of the 4&#160;disease process categories. The expanded organizational paradigm is shown in <span class="xref-table">Table&#160;1-2</span>.</p>
		</div>
		</div>
		<div id="_idContainer002" class="Basic-Text-Frame">
			<p class="NEW-Title ParaOverride-6"><span class="CharOverride-2">Ophthalmic</span></p>
			<p class="NEW-Title ParaOverride-6"><span class="CharOverride-2">Pathology</span></p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer003" class="_idGenObjectStyleOverride-1">
			</div>
		</div>
		<div id="_idContainer004" class="Basic-Text-Frame">
			<p class="Year---Cover"><span class="CharOverride-3">PART I</span></p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer005" class="_idGenObjectStyleOverride-2">
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer006" class="_idGenObjectStyleOverride-3">
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer009">
				<div id="_idContainer007" class="_idGenObjectStyleOverride-4">
					<img class="_idGenObjectAttribute-1" src="BCSC1718_S04_C01_p001_012-web-resources/image/AAX-1555.png" alt="" />
				</div>
				<div id="_idContainer008" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 1-1</span> Orbital teratoma with tissue from 3&#160;germ layers. Note gastrointestinal mucosa <span class="figure-caption-italic">(asterisk)</span> and cartilage <span class="figure-caption-italic">(arrows)</span> in the tumor. <span class="figure-source-note">(Courtesy of Hans E. Grossniklaus, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer012">
				<div id="_idContainer010" class="_idGenObjectStyleOverride-4">
					<img class="_idGenObjectAttribute-1" src="BCSC1718_S04_C01_p001_012-web-resources/image/AAX-1560.jpg" alt="" />
				</div>
				<div id="_idContainer011" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 1-2</span> Polymorphonuclear leukocyte with <br />multisegmented nucleus. <span class="figure-source-note">(Courtesy of Hans E. Gross&#173;niklaus, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer015">
				<div id="_idContainer013" class="_idGenObjectStyleOverride-4">
					<img class="_idGenObjectAttribute-1" src="BCSC1718_S04_C01_p001_012-web-resources/image/AAX-1562.jpg" alt="" />
				</div>
				<div id="_idContainer014" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 1</span><span class="figure-number">-</span><span class="figure-number">4</span> Basophil with intracytoplasmic <br />basophilic granules. <span class="figure-source-note">(Courtesy of Hans E. Grossniklaus, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer016" class="_idGenObjectStyleOverride-4">
				<img class="_idGenObjectAttribute-1" src="BCSC1718_S04_C01_p001_012-web-resources/image/AAX-1564.jpg" alt="" />
			</div>
		</div>
		<div id="_idContainer017" class="Basic-Text-Frame">
			<p class="figure-caption"><span class="figure-number">Figure 1-6</span> Lymphocyte with small, hyperchromatic nucleus and scant cytoplasm. <span class="figure-source-note">(Courtesy of Hans E. Grossniklaus, MD.)</span></p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer020">
				<div id="_idContainer018" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 1-5</span> Monocyte with indented nucleus. <span class="figure-source-note">(Courtesy of Hans E. Grossniklaus, MD.)</span></p>
				</div>
				<div id="_idContainer019" class="_idGenObjectStyleOverride-4">
					<img class="_idGenObjectAttribute-1" src="BCSC1718_S04_C01_p001_012-web-resources/image/AAX-1563.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer023">
				<div id="_idContainer021" class="_idGenObjectStyleOverride-4">
					<img class="_idGenObjectAttribute-1" src="BCSC1718_S04_C01_p001_012-web-resources/image/AAX-1561.jpg" alt="" />
				</div>
				<div id="_idContainer022" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 1-3</span> Eosinophil with bilobed nucleus and intracytoplasmic eosinophilic granules. <span class="figure-source-note">(Courtesy of Hans E. Grossniklaus, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer026">
				<div id="_idContainer024" class="_idGenObjectStyleOverride-4">
					<img class="_idGenObjectAttribute-1" src="BCSC1718_S04_C01_p001_012-web-resources/image/AAX-1565.jpg" alt="" />
				</div>
				<div id="_idContainer025" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 1-7</span> Noncaseating granulomas, or “hard” tubercles, are formed by aggregates of epithelioid histiocytes. <span class="figure-source-note">(Courtesy of Hans E. Grossniklaus, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer033">
				<div id="_idContainer029">
					<div id="_idContainer027" class="_idGenObjectStyleOverride-4">
						<img class="_idGenObjectAttribute-1" src="BCSC1718_S04_C01_p001_012-web-resources/image/AAX-1566.png" alt="" />
					</div>
					<div id="_idContainer028" class="Basic-Text-Frame">
						<p class="figure-caption"><span class="figure-number">Figure 1-8</span> Granulomas with necrotic centers <span class="figure-caption-italic">(arrows)</span> are classified as caseating granulomas. <span class="figure-source-note">(Courtesy of Hans E. Grossniklaus, MD.)</span></p>
					</div>
				</div>
				<div id="_idContainer032">
					<div id="_idContainer030" class="_idGenObjectStyleOverride-4">
						<img class="_idGenObjectAttribute-1" src="BCSC1718_S04_C01_p001_012-web-resources/image/AAX-1567.png" alt="" />
					</div>
					<div id="_idContainer031" class="Basic-Text-Frame">
						<p class="figure-caption"><span class="figure-number">Figure 1-9</span> Langhans giant cell. Note peripheral arrangement of nuclei.</p>
					</div>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer036">
				<div id="_idContainer034" class="_idGenObjectStyleOverride-4">
					<img class="_idGenObjectAttribute-1" src="BCSC1718_S04_C01_p001_012-web-resources/image/AAX-1556.jpg" alt="" />
				</div>
				<div id="_idContainer035" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 1-10</span> Touton giant cell. Note central eosinophilic cytoplasm and annulus of nuclei surrounded by lipid-&#173;filled clear zone.</p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer039">
				<div id="_idContainer037" class="_idGenObjectStyleOverride-4">
					<img class="_idGenObjectAttribute-1" src="BCSC1718_S04_C01_p001_012-web-resources/image/AAX-1557.jpg" alt="" />
				</div>
				<div id="_idContainer038" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 1-11</span> Foreign body giant cell. Note haphazardly arranged nuclei.</p>
				</div>
			</div>
		</div>
		<div id="_idContainer040" class="Basic-Text-Frame">
			<table id="table001" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-1" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-3" />
					<col class="_idGenTableRowColumn-4" />
					<col class="_idGenTableRowColumn-5" />
					<col class="_idGenTableRowColumn-4" />
					<col class="_idGenTableRowColumn-6" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table CellOverride-1 _idGenCellOverride-1" colspan="7">
							<p class="table-title"><span class="table-number">Table 1-1</span> Classification of Neoplasia</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Tissue Origin</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Benign</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Malignant</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Growth Pattern</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Epithelium</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Hyperplasia/adenoma</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Carcinoma</p>
							<p class="table-body">Adenocarcinoma</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Cords </p>
							<p class="table-body">Tubules</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-10">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Soft tissue</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Topography + <span class="CharOverride-4">oma</span></p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Topography + <span class="CharOverride-4">sarcoma</span></p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Coherent sheets</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-11">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Hematopoietic tissue</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Hyperplasia/infiltrate</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Leukemia </p>
							<p class="table-body">Lymphoma</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Loosely arranged</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div id="_idContainer041" class="_idGenObjectStyleOverride-4">
			<p class="page-elements_rhr"><span class="rh-chap-num CharOverride-5">Chapter 1: </span>Introduction to Part I <span class="rh-bullet">●</span>  </p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer044">
				<div id="_idContainer042" class="_idGenObjectStyleOverride-4">
					<img class="_idGenObjectAttribute-1" src="BCSC1718_S04_C01_p001_012-web-resources/image/AAX-1559.png" alt="" />
				</div>
				<div id="_idContainer043" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 1-12</span> General classification and growth patterns of malignant tumors. <span class="figure-source-note">(Illustration by <br /></span><span class="figure-source-note">Christine Gralapp.)</span></p>
				</div>
			</div>
		</div>
		<div id="_idContainer045" class="Basic-Text-Frame">
			<table id="table002" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-12" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table CellOverride-6">
							<p class="table-title"><span class="table-number">Table 1-2</span> Organizational Paradigm for Ophthalmic Pathology</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-13">
						<td class="Basic-Table CellOverride-7">
							<p class="table-head">Topography</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-8">
							<p class="table-indent-1">Conjunctiva</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9">
							<p class="table-indent-1">Cornea</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9">
							<p class="table-indent-1">Anterior chamber/trabecular meshwork</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9">
							<p class="table-indent-1">Sclera</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9">
							<p class="table-indent-1">Lens</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9">
							<p class="table-indent-1">Vitreous</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9">
							<p class="table-indent-1">Retina</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9">
							<p class="table-indent-1">Uveal tract</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9">
							<p class="table-indent-1">Eyelids</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9">
							<p class="table-indent-1">Orbit</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9">
							<p class="table-indent-1">Optic nerve</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-15">
						<td class="Basic-Table CellOverride-10">
							<p class="table-head">Disease process</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9">
							<p class="table-indent-1">Congenital anomaly</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9">
							<p class="table-indent-2">Choristoma versus hamartoma</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9">
							<p class="table-indent-1">Inflammation</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9">
							<p class="table-indent-2">Acute versus chronic</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9">
							<p class="table-indent-2">Focal versus diffuse</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9">
							<p class="table-indent-2">Granulomatous versus nongranulomatous</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9">
							<p class="table-indent-1">Degeneration (includes dystrophy)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9">
							<p class="table-indent-1">Neoplasia</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9">
							<p class="table-indent-2">Benign versus malignant</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9">
							<p class="table-indent-2">Epithelial versus soft tissue versus hematopoietic</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-15">
						<td class="Basic-Table CellOverride-10">
							<p class="table-head">General diagnosis</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9">
							<p class="table-indent-1">Index feature</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-15">
						<td class="Basic-Table CellOverride-10">
							<p class="table-head">Differential diagnosis</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-11">
							<p class="table-indent-1">Limited list of conditions resulting from pathologic processes identified above</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
	</body>
</html>
